These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2472426)
1. Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester. Jonas AJ; Butler IJ J Clin Invest; 1989 Jul; 84(1):200-4. PubMed ID: 2472426 [TBL] [Abstract][Full Text] [Related]
2. Studies on intestinal absorption of amino acids and a dipeptide in a case of Hartnup disease. Navab F; Asatoor AM Gut; 1970 May; 11(5):373-9. PubMed ID: 4246731 [TBL] [Abstract][Full Text] [Related]
3. A clinicobiochemical study of tryptophan and other plasma and urinary amino acids in the family with Hartnup disease. Milovanović DD Adv Exp Med Biol; 2003; 527():325-35. PubMed ID: 15206746 [TBL] [Abstract][Full Text] [Related]
4. Use of ethyl esters of tryptophan to bypass the absorption defect in Hartnup disease. Nutr Rev; 1990 Jan; 48(1):22-4. PubMed ID: 2336209 [No Abstract] [Full Text] [Related]
5. Transport of dibasic amino acids, cystine, and tryptophan by cultured human fibroblasts: absence of a defect in cystinuria and Hartnup disease. Groth U; Rosenberg LE J Clin Invest; 1972 Aug; 51(8):2130-42. PubMed ID: 5054467 [TBL] [Abstract][Full Text] [Related]
19. A longitudinal study of tryptophan involvement in hepatic coma. Hutson DG; Ono J; Dombro RS; Levi JU; Livingstone A; Zeppa R Am J Surg; 1979 Feb; 137(2):235-9. PubMed ID: 426181 [TBL] [Abstract][Full Text] [Related]
20. Tryptophan and its metabolites in a family with Hartnup disease. Milovanović DD; Milovanović L; Stanković B; Radulović D Adv Exp Med Biol; 1991; 294():669-74. PubMed ID: 1722956 [No Abstract] [Full Text] [Related] [Next] [New Search]